Search Results for "fluid"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for fluid. Results 71 to 80 of 206 total matches.
Ektachem DT Analyzers For The Office
The Medical Letter on Drugs and Therapeutics • Dec 30, 1988 (Issue 782)
reference fluid at the same time.
CALIBRATION AND CONTROLS — Control sera, which are provided, should ...
(Kodak) perform clinical chemistry tests using desk-top instruments, microliter samples and postage-stamp-sized analytical slides containing dry reagents layered on clear polyester and mounted in plastic. The system requires no wet reagents, except for electrolyte determinations, and is designed to require a minimum amount of training to operate. A single analysis takes about five minutes.
Ifosfamide and Mesna
The Medical Letter on Drugs and Therapeutics • Nov 03, 1989 (Issue 804)
marrow restoration. At least two liters of
oral or IV fluid should be given daily. The manufacturer ...
Ifosfamide (Ifex - Mead Johnson), a synthetic analog of cyclophosphamide (Cytoxan; and others), has been approved by the US Food and Drug Administration (FDA) for concurrent use with other drugs in third-line chemotherapy of metastatic germ-cell testicular cancer. Given concomitantly, a synthetic sulfhydryl compound known as mesna (Mesnex - Asta) acts in the urine to detoxify metabolites of ifosfamide that cause hemorrhagic cystitis (H Burkert, Cancer Treat Rev, 10 suppl A:175, 1983). Ifosfamide and mesna are available together from Bristol-Myers Oncology Division.
Samarium-153 Lexidronam for Painful Bone Metastases
The Medical Letter on Drugs and Therapeutics • Aug 29, 1997 (Issue 1008)
over a period of one minute. The patient should ingest a minimum of
500 ml of fluids before injection ...
Samarium-153 lexidronam (Quadramet - Dupont Pharma) has been approved by the FDA for relief of pain in patients with osteoblastic bone metastases. Strontium-89 (Metastron) has been available for several years for this indication (Medical Letter, 35:102, 1993).
Rifapentine--A Long-Acting Rifamycin for Tuberculosis
The Medical Letter on Drugs and Therapeutics • Feb 26, 1999 (Issue 1047)
-orange discoloration of
body fluids and stains contact lenses. In clinical trials with isoniazid, rates ...
Rifapentine, a long-acting analog of rifampin developed in the 1960's, has received an accelerated approval from the FDA for oral use, with at least one other drug, in the treatment of pulmonary tuberculosis.
An Expanded Pneumococcal Vaccine (Prevnar 13) for Infants and Children
The Medical Letter on Drugs and Therapeutics • Aug 23, 2010 (Issue 1345)
, sickle cell disease,
asplenia, cochlear implant, cerebrospinal fluid
leak) should receive 2 doses ...
The FDA has licensed a 13-valent conjugate pneumococcal vaccine (PCV13; Prevnar 13 – Pfizer) for
the prevention of invasive pneumococcal disease (IPD) in infants and children <6 years old. It replaces
Prevnar (PCV7). An unconjugated 23-valent polysaccharide vaccine (PPSV23; Pneumovax 23 – Merck) is FDA-approved for use in adults.
Testosterone Topical Solution (Axiron) for Hypogonadism
The Medical Letter on Drugs and Therapeutics • Jul 11, 2011 (Issue 1368)
of
INR or prothrombin time is recommended if androgens
and anticoagulants are used concurrently. Fluid ...
The Medical Letter recently reviewed a topical gel formulation
of testosterone (Fortesta) for treatment of
hypogonadism in men. A topical testosterone replacement
product for application to the axilla, Axiron (Lilly)
solution, has now become available for the same indication.
This site of application presumably minimizes
the risk of transferring the drug to a family member or
sexual partner.
Pioglitazone/Metformin (Actoplus met)
The Medical Letter on Drugs and Therapeutics • Jan 30, 2006 (Issue 1227)
, can cause or
exacerbate fluid retention, possibly through an effect on
renal sodium excretion,
7 ...
For patients with diabetes poorly controlled with a single oral drug, addition of a second drug with a different mechanism can be helpful. A fixed-dose combination (Actoplus met - Takeda) of two widely used antihyperglycemic drugs, the thiazolidinedione pioglitazone (Actos) and the biguanide metformin (Glucophage, and others), has been approved by the FDA for management of type 2 diabetes. It is indicated for patients already being treated with both pioglitazone and metformin or as second-line therapy for those not adequately controlled with either metformin or pioglitazone alone....
The Cervical Cap
The Medical Letter on Drugs and Therapeutics • Oct 07, 1988 (Issue 776)
of menstrual fluids.
INSTRUCTIONS — The package insert indicates that the patient should fill the cap about ...
The US Food and Drug Administration recently approved the marketing of a cervical cap (Prentif Cavity-Rim Cervical Cap - Lamberts Ltd, England), a contraceptive device that has been used in one form or another for many years (JP Koch, Contraception, 25:161, 1982). The cap is being distributed in the USA and Canada by Cervical Cap (CxC), Ltd, PO Box 38003-292, Los Gatos, CA 95031, telephone 408-358-6264; the distributor will make the caps available only to practitioners who have attended training seminars.
ACE Inhibitors for Congestive Heart Failure
The Medical Letter on Drugs and Therapeutics • Oct 21, 1988 (Issue 777)
other
oral agent and are the only drugs that can control fluid retention. Diuretics alone, however, often ...
The angiotensin-converting enzyme (ACE) inhibitors captopril (Capoten - Squibb) and enalapril (Vasotec - Merck) are now widely used to treat chronic congestive heart failure that has not responded adequately to digitalis and diuretics (Medical Letter, 30:13, Jan 29, 1988). Recently, some cardiologists have debated whether ACE inhibitors should also be used as first-line agents for treatment of this condition (WW Parmley et al, J Am Coll Cardiol, 12:265, July 1988).
Cefmetazole Sodium (Zefazone)
The Medical Letter on Drugs and Therapeutics • Jul 13, 1990 (Issue 822)
of cefmetazole in tissues and unobstructed
bile, but no data are available on cerebrospinal-fluid concentrations ...
Cefmetazole sodium (Zefazone - Upjohn), a second-generation parenteral cephalosporin, was recently marketed in the USA for intravenous (IV) treatment of various infections caused by susceptible organisms. Like cefotetan (Cefotan), cefamandole (Mandol), cefoperazone (Cefobid), and moxalactam (Moxam), cefmetazole contains a methylthiotetrazole group that has been associated with prothrombin deficiency.